Literature DB >> 19584208

The new lung cancer staging system.

Frank C Detterbeck1, Daniel J Boffa2, Lynn T Tanoue3.   

Abstract

The International Association for the Study of Lung Cancer (IASLC) has conducted an extensive initiative to inform the revision of the lung cancer staging system. This involved development of an international database along with extensive analysis of a large population of patients and their prognoses. This article reviews the recommendations of the IASLC International Staging Committee for the definitions for the TNM descriptors and the stage grouping in the new non-small cell lung cancer staging system.

Entities:  

Mesh:

Year:  2009        PMID: 19584208     DOI: 10.1378/chest.08-0978

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  315 in total

1.  Analysis of the molecular and clinicopathologic features of surgically resected lung adenocarcinoma in patients under 40 years old.

Authors:  Ting Ye; Yunjian Pan; Rui Wang; Haichuan Hu; Yang Zhang; Hang Li; Lei Wang; Yihua Sun; Haiquan Chen
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

Review 2.  The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome.

Authors:  Romain Remark; Christian Becker; Jorge E Gomez; Diane Damotte; Marie-Caroline Dieu-Nosjean; Catherine Sautès-Fridman; Wolf-Herman Fridman; Charles A Powell; Nasser K Altorki; Miriam Merad; Sacha Gnjatic
Journal:  Am J Respir Crit Care Med       Date:  2015-02-15       Impact factor: 21.405

3.  Down-regulation of lysyl oxidase-like 2 (LOXL2) is associated with disease progression in lung adenocarcinomas.

Authors:  Ping Zhan; Xiao-Kun Shen; Qian Qian; Ji-Ping Zhu; Yu Zhang; Hai-Yan Xie; Chuen-Hua Xu; Ke-Ke Hao; Wei Hu; Ning Xia; Guo-Jun Lu; Li-Ke Yu
Journal:  Med Oncol       Date:  2011-04-26       Impact factor: 3.064

4.  Muscle plombage for extensive bronchial necrosis after right lower lobectomy.

Authors:  Kenji Tetsuka; Shunsuke Endo; Yoshihiko Kanai; Shinichi Otani; Shinichi Yamamoto; Tsuyoshi Hasegawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-01-13

5.  Detection of noncalcified pulmonary nodules on low-dose MDCT: comparison of the sensitivity of two CAD systems by using a double reference standard.

Authors:  A R Larici; M Amato; P Ordóñez; F Maggi; L Menchini; A Caulo; L Calandriello; G Vallati; S Giunta; M Crecco; L Bonomo
Journal:  Radiol Med       Date:  2012-02-10       Impact factor: 3.469

Review 6.  Progress in the management of limited-stage small cell lung cancer.

Authors:  Arya Amini; Lauren A Byers; James W Welsh; Ritsuko U Komaki
Journal:  Cancer       Date:  2013-12-10       Impact factor: 6.860

7.  Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome.

Authors:  Véronique M Braud; Jérôme Biton; Etienne Becht; Samantha Knockaert; Audrey Mansuet-Lupo; Estelle Cosson; Diane Damotte; Marco Alifano; Pierre Validire; Fabienne Anjuère; Isabelle Cremer; Nicolas Girard; Dominique Gossot; Agathe Seguin-Givelet; Marie-Caroline Dieu-Nosjean; Claire Germain
Journal:  Oncoimmunology       Date:  2018-01-29       Impact factor: 8.110

8.  High Sam68 expression predicts poor prognosis in non-small cell lung cancer.

Authors:  Z Zhang; Y Xu; N Sun; M Zhang; J Xie; Z Jiang
Journal:  Clin Transl Oncol       Date:  2014-02-13       Impact factor: 3.405

9.  Programmed death ligand-1 expression in non-small cell lung cancer.

Authors:  Vamsidhar Velcheti; Kurt A Schalper; Daniel E Carvajal; Valsamo K Anagnostou; Konstantinos N Syrigos; Mario Sznol; Roy S Herbst; Scott N Gettinger; Lieping Chen; David L Rimm
Journal:  Lab Invest       Date:  2013-11-11       Impact factor: 5.662

10.  Complete response of 7 years' duration after chemoradiotherapy followed by gefitinib in a patient with intramedullary spinal cord metastasis from lung adenocarcinoma.

Authors:  Yoshinobu Hata; Yujiro Takai; Hiroshi Takahashi; Keigo Takagi; Kazutoshi Isobe; Chikako Hasegawa; Kazutoshi Shibuya; Hidenori Goto; Kazuyoshi Tamaki; Fumitomo Sato; Hajime Otsuka
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.